Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy.
about
Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIVAssociation between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: a longitudinal case control studyLevels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB.Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory responseVery low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis.Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals.25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settingsVitamin D status is associated with mortality, morbidity, and growth failure among a prospective cohort of HIV-infected and HIV-exposed Tanzanian infants.Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort studyA serum vitamin D level <25nmol/l pose high tuberculosis risk: a meta-analysisTuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapyDo countries rely on the World Health Organization for translating research findings into clinical guidelines? A case study.Vitamin D status and TB treatment outcomes in adult patients in Tanzania: a cohort study.Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial.Vitamin D and tuberculosis: a review on a hot topic.Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells.Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study.Effect of maternal vitamin D3 supplementation on maternal health, birth outcomes, and infant growth among HIV-infected Tanzanian pregnant women: study protocol for a randomized controlled trial.Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.Vitamin D: a new anti-infective agent?Low vitamin D exposure is associated with higher risk of infection in renal transplant recipients.The role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease.Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder.Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study.Reply to Séraphin.Continued Interest and Controversy: Vitamin D in HIV.Vitamin D deficiency and periodontal clinical attachment loss in HIV-seropositive women: A secondary analysis conducted in the Women's Interagency HIV Study (WIHS).[Vitamin D : More than just a bone hormone].
P2860
Q27011921-DED690EE-92B7-467E-B905-B07C4D73AEA9Q28596430-95D828BC-C188-43CE-9498-3823876C780CQ33814734-6BCD2E2A-C917-48A9-B419-20EF47AC4433Q33948630-8B3110FA-2021-44C7-B824-A56DA0D994CCQ33953918-3F983F1C-66C7-471D-8C4F-C0E91BB04F11Q34016783-B620DEDC-85E6-4011-BE38-B29138B78A3BQ34076892-7D3DB22D-2F02-4CCE-975D-437920E5E5E8Q34684189-E7289A63-EDE1-4951-9445-287F2065035FQ34994918-2C8F74F1-CC55-4F9C-AED1-539D71822B4AQ35621717-FA061D2D-3AB3-4878-B956-FDD42244165AQ36078532-92B05676-4BB4-48AD-B9CD-0E5028A6D823Q37316144-C62CD9CE-F17F-4C49-8F7E-106FCA90CCA3Q37342397-778975C1-59FA-480A-AE81-B4A53897F4D3Q37635220-E564ED2E-B2E5-4C35-BCB1-B22AA9E55FA1Q38522400-735ECAA9-E1B1-4D70-9444-4C709DACBBDBQ38764819-838825AE-5E7A-49D1-942C-04B4CA8102CEQ39517160-DBED524A-EFF4-4385-BD66-B6B27C53506EQ40058675-1A5CD0F0-C565-47AD-B71E-9269A10DE1C6Q40191000-0304E3F2-6FB7-4659-A5ED-50156C2B45BFQ40215831-1D9308CC-A119-44E0-8920-E9548048A8ECQ40293541-13E1FF4D-8CE0-46AD-8E15-EC59EA8E33D6Q40375467-0340BE0E-2CF6-487C-AAE4-EA31500E2B63Q40519915-F26227CC-BD3B-4AD9-8AE2-5BB99BF7AD2BQ40563423-B7748C3C-C85E-4323-836A-827C8A57CBEFQ41719708-2A358B16-CF6D-4C37-9B60-B8264D545AFAQ43195091-E09EAB5D-3598-462A-8520-F83FF72B06D9Q54224147-DD12031D-8610-4771-9D21-1601EDF86031Q54254278-A63E83BB-DA51-4378-9DEB-621D84802218Q54574587-31A92B09-A8E6-42E4-A506-97637426FB57
P2860
Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Vitamin D status and incidence ...... iating antiretroviral therapy.
@ast
Vitamin D status and incidence ...... iating antiretroviral therapy.
@en
type
label
Vitamin D status and incidence ...... iating antiretroviral therapy.
@ast
Vitamin D status and incidence ...... iating antiretroviral therapy.
@en
prefLabel
Vitamin D status and incidence ...... iating antiretroviral therapy.
@ast
Vitamin D status and incidence ...... iating antiretroviral therapy.
@en
P2093
P2860
P50
P921
P356
P1476
Vitamin D status and incidence ...... iating antiretroviral therapy.
@en
P2093
Ferdinand M Mugusi
Molin Wang
Sheila Isanaka
P2860
P304
P356
10.1093/INFDIS/JIS693
P407
P577
2012-11-16T00:00:00Z